Radovich Peter 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jan 27, 2025
Insider Transaction Report
Form 4
Radovich Peter
PRESIDENT AND COO
Transactions
- Exercise/Conversion
Common Stock
2025-01-23+5,750→ 32,765 total - Sale
Common Stock
2025-01-24$47.92/sh−3,177$152,256→ 29,588 total - Exercise/Conversion
Restricted Stock Units
2025-01-23−5,750→ 11,500 total→ Common Stock (5,750 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- [F2]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F3]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.